Literature DB >> 23166176

Hypertension, secondary to a renal artery aneurysm, treated by ex vivo aneurysm repair and autotransplantation.

Hitesh Prajapati1, Amy McCallum, Eric Finlay.   

Abstract

Hypertension is becoming a more common problem in childhood and adolescence. About 5-10% of paediatric patients with hypertension have underlying renovascular disease. Although renal artery aneurysms (RAAs) are an uncommon cause of disease of the renal vessels, they are recognised as a cause of hypertension. We describe a 15-year-old man with symptomatic hypertension who after extensive investigation was found to have a right RAA. Our patient responded to conservative management with two antihypertensive agents, but as a young sports enthusiast, he was keen to pursue more definitive options. Complex anatomy of the aneurysm precluded the use of endovascular treatment. Surgical options were explored, and after counselling, our patient underwent a nephrectomy, ex vivo aneurysm repair and autotransplantation with which his hypertension resolved. Our case highlights the difficulty of diagnosing RAAs in hypertensive patients and that, in carefully selected patients, invasive surgical intervention of RAAs is a viable treatment option.

Entities:  

Mesh:

Year:  2012        PMID: 23166176      PMCID: PMC4543840          DOI: 10.1136/bcr-2012-007362

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

Review 1.  Hypertension in children: new trends and challenges.

Authors:  Janusz Feber; Maheen Ahmed
Journal:  Clin Sci (Lond)       Date:  2010-05-14       Impact factor: 6.124

2.  Repair of complex renal artery aneurysms by laparoscopic nephrectomy with ex vivo repair and autotransplantation.

Authors:  Katherine A Gallagher; Michael W Phelan; Tina Stern; Stephen T Bartlett
Journal:  J Vasc Surg       Date:  2008-09-19       Impact factor: 4.268

3.  Renal aneurysms and pseudoaneurysms.

Authors:  Marco Cura; Fadi Elmerhi; Alejandro Bugnogne; Raul Palacios; Rajeev Suri; Timothy Dalsaso
Journal:  Clin Imaging       Date:  2011 Jan-Feb       Impact factor: 1.605

Review 4.  Diagnosis, management, and future developments of fibromuscular dysplasia.

Authors:  Jeffrey W Olin; Brett A Sealove
Journal:  J Vasc Surg       Date:  2011-01-13       Impact factor: 4.268

5.  Pediatric renovascular hypertension: 132 primary and 30 secondary operations in 97 children.

Authors:  James C Stanley; Enrique Criado; Gilbert R Upchurch; Patrick D Brophy; Kyung J Cho; John E Rectenwald; David B Kershaw; David M Williams; Ramon Berguer; Peter K Henke; Thomas W Wakefield
Journal:  J Vasc Surg       Date:  2006-10-20       Impact factor: 4.268

6.  Renal artery aneurysm in a hypertensive child treated by percutaneous coil embolization.

Authors:  Sevtap Gümüştaş; Ercüment Ciftçi; Zelal Bircan
Journal:  Pediatr Radiol       Date:  2010-02-10

Review 7.  Pediatric approach to hypertension.

Authors:  Tammy M Brady; Leonard G Feld
Journal:  Semin Nephrol       Date:  2009-07       Impact factor: 5.299

8.  Renovascular hypertension and intrarenal artery aneurysms in a preschool child.

Authors:  David J Hobbs; Gina-Marie Barletta; Jeanne A Mowry; Timothy E Bunchman
Journal:  Pediatr Radiol       Date:  2009-05-07

9.  Reno-vascular hypertension in childhood: a nationwide survey.

Authors:  Aysun K Bayazit; Fatos Yalcinkaya; Nilgun Cakar; Ali Duzova; Zelal Bircan; Aysin Bakkaloglu; Nur Canpolat; Nazl Kara; Aydan Sirin; Mesiha Ekim; Ayse Oner; Sema Akman; Sevgi Mir; Esra Baskin; Hakan M Poyrazoglu; Aytul Noyan; Ipek Akil; Sevcan Bakkaloglu; Alper Soylu
Journal:  Pediatr Nephrol       Date:  2007-05-30       Impact factor: 3.714

Review 10.  Imaging in the evaluation of renovascular disease.

Authors:  Kjell Tullus; Derek J Roebuck; Clare A McLaren; Stephen D Marks
Journal:  Pediatr Nephrol       Date:  2009-10-24       Impact factor: 3.714

View more
  1 in total

Review 1.  Renal artery embolization-indications, technical approaches and outcomes.

Authors:  Arnaud Muller; Olivier Rouvière
Journal:  Nat Rev Nephrol       Date:  2014-12-23       Impact factor: 28.314

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.